Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective therapies. The challenges associated with early detection and the highly aggressive nature of pancreatic cancer have limited treatment options, underscoring the urgent need for better disease-modifying ther...

Full description

Bibliographic Details
Main Authors: Yang Li, Kai-di Yang, Hao-yu Duan, Ya-nan Du, Jun-feng Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1231503/full
_version_ 1797756414499749888
author Yang Li
Yang Li
Kai-di Yang
Kai-di Yang
Hao-yu Duan
Hao-yu Duan
Ya-nan Du
Ya-nan Du
Jun-feng Ye
Jun-feng Ye
author_facet Yang Li
Yang Li
Kai-di Yang
Kai-di Yang
Hao-yu Duan
Hao-yu Duan
Ya-nan Du
Ya-nan Du
Jun-feng Ye
Jun-feng Ye
author_sort Yang Li
collection DOAJ
description Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective therapies. The challenges associated with early detection and the highly aggressive nature of pancreatic cancer have limited treatment options, underscoring the urgent need for better disease-modifying therapies. Peptide-based biotherapeutics have become an attractive area of research due to their favorable properties such as high selectivity and affinity, chemical modifiability, good tissue permeability, and easy metabolism and excretion. Phage display, a powerful technique for identifying peptides with high affinity and specificity for their target molecules, has emerged as a key tool in the discovery of peptide-based drugs. Phage display technology involves the use of bacteriophages to express peptide libraries, which are then screened against a target of interest to identify peptides with desired properties. This approach has shown great promise in cancer diagnosis and treatment, with potential applications in targeting cancer cells and developing new therapies. In this comprehensive review, we provide an overview of the basic biology of phage vectors, the principles of phage library construction, and various methods for binding affinity assessment. We then describe the applications of phage display in pancreatic cancer therapy, targeted drug delivery, and early detection. Despite its promising potential, there are still challenges to be addressed, such as optimizing the selection process and improving the pharmacokinetic properties of phage-based drugs. Nevertheless, phage display represents a promising approach for the development of novel targeted therapies in pancreatic cancer and other tumors.
first_indexed 2024-03-12T18:01:03Z
format Article
id doaj.art-0e4910b0248c4ea5831f96f34a8e193b
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-12T18:01:03Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-0e4910b0248c4ea5831f96f34a8e193b2023-08-02T10:11:48ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-08-011410.3389/fmicb.2023.12315031231503Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approachYang Li0Yang Li1Kai-di Yang2Kai-di Yang3Hao-yu Duan4Hao-yu Duan5Ya-nan Du6Ya-nan Du7Jun-feng Ye8Jun-feng Ye9General Surgery Center, First Hospital of Jilin University, Changchun, ChinaSchool of Nursing, Jilin University, Changchun, ChinaGeneral Surgery Center, First Hospital of Jilin University, Changchun, ChinaSchool of Nursing, Jilin University, Changchun, ChinaGeneral Surgery Center, First Hospital of Jilin University, Changchun, ChinaSchool of Nursing, Jilin University, Changchun, ChinaGeneral Surgery Center, First Hospital of Jilin University, Changchun, ChinaSchool of Nursing, Jilin University, Changchun, ChinaGeneral Surgery Center, First Hospital of Jilin University, Changchun, ChinaSchool of Nursing, Jilin University, Changchun, ChinaPancreatic cancer is a devastating disease with a high mortality rate and a lack of effective therapies. The challenges associated with early detection and the highly aggressive nature of pancreatic cancer have limited treatment options, underscoring the urgent need for better disease-modifying therapies. Peptide-based biotherapeutics have become an attractive area of research due to their favorable properties such as high selectivity and affinity, chemical modifiability, good tissue permeability, and easy metabolism and excretion. Phage display, a powerful technique for identifying peptides with high affinity and specificity for their target molecules, has emerged as a key tool in the discovery of peptide-based drugs. Phage display technology involves the use of bacteriophages to express peptide libraries, which are then screened against a target of interest to identify peptides with desired properties. This approach has shown great promise in cancer diagnosis and treatment, with potential applications in targeting cancer cells and developing new therapies. In this comprehensive review, we provide an overview of the basic biology of phage vectors, the principles of phage library construction, and various methods for binding affinity assessment. We then describe the applications of phage display in pancreatic cancer therapy, targeted drug delivery, and early detection. Despite its promising potential, there are still challenges to be addressed, such as optimizing the selection process and improving the pharmacokinetic properties of phage-based drugs. Nevertheless, phage display represents a promising approach for the development of novel targeted therapies in pancreatic cancer and other tumors.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1231503/fullpancreatic cancerphage displaypeptide therapycancer targetingearly detection
spellingShingle Yang Li
Yang Li
Kai-di Yang
Kai-di Yang
Hao-yu Duan
Hao-yu Duan
Ya-nan Du
Ya-nan Du
Jun-feng Ye
Jun-feng Ye
Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
Frontiers in Microbiology
pancreatic cancer
phage display
peptide therapy
cancer targeting
early detection
title Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
title_full Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
title_fullStr Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
title_full_unstemmed Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
title_short Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
title_sort phage based peptides for pancreatic cancer diagnosis and treatment alternative approach
topic pancreatic cancer
phage display
peptide therapy
cancer targeting
early detection
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1231503/full
work_keys_str_mv AT yangli phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT yangli phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT kaidiyang phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT kaidiyang phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT haoyuduan phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT haoyuduan phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT yanandu phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT yanandu phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT junfengye phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach
AT junfengye phagebasedpeptidesforpancreaticcancerdiagnosisandtreatmentalternativeapproach